Roche, Foundation Medicine Execs Discuss Rationale Behind Broad Diagnostics, Commercial Partnership | GenomeWeb

NEW YORK (GenomeWeb) – As part of their strategic partnership announced yesterday, Roche and Foundation Medicine plan to collaborate closely on the R&D side to develop new products, and on the commercial side to broaden the reach of Foundation Medicine's tumor profiling tests in the US and abroad.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.